Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

44.23
-0.8250-1.83%
Volume:7.11M
Turnover:313.46M
Market Cap:64.09B
PE:17.92
High:44.99
Open:44.32
Low:43.68
Close:45.05
52wk High:105.65
52wk Low:42.20
Shares:1.45B
Float Shares:1.45B
Volume Ratio:0.59
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.47
EPS(LYR):1.94
ROE:15.34%
ROA:6.19%
PB:2.57
PE(LYR):22.80

Loading ...

Boston Scientific Shares Reverse Course; Last Down 8.9% Premarket

THOMSON REUTERS
·
Jul 29

Stock Track | Boston Scientific Plunges 6.67% in Pre-market as Lowered Profit Forecast, Watchman Device Woes Spook Investors

Stock Track
·
Jul 29

Boston Scientific Exec Says Co Expects Its Electrophysiology Business to Improve "Nicely" in H2 2027

THOMSON REUTERS
·
Jul 29

Boston Scientific Exec Says Co Expects 2027 Watchman Trends to Improve from H2 2026 Levels

THOMSON REUTERS
·
Jul 29

Boston Scientific Exec Says Co NOW Expects Global Watchman Sales Growth to be Flat to Low Single Digits in 2026

THOMSON REUTERS
·
Jul 29

Boston Scientific Exec Says Second Half Watchman Revenue is Expected to Decline at a Mid- to High-Single-Digit Rate Year over Year

THOMSON REUTERS
·
Jul 29

Boston Scientific Exec Says Co NOW Expects H2 2026 to be More "Pressured" than Originally Anticipated - Conf Call

THOMSON REUTERS
·
Jul 29

Boston Scientific Exec Says Co Expect EPS and Revenue Growth to Improve Meaningfully in 2028

THOMSON REUTERS
·
Jul 29

Boston Scientific Exec Says Updated Forecast Reflects a "Realistic View" of H2 2026

THOMSON REUTERS
·
Jul 29

U.S. Stocks on the MOVE-Seagate, Bloom Energy, Generac

Reuters
·
Jul 29

Boston Scientific Shares up 3.7% Premarket After Q2 Results Beat

THOMSON REUTERS
·
Jul 29

Boston Scientific Rises After Quarterly Results Beat Estimates

Reuters
·
Jul 29

Boston Scientific Logs Higher 2Q, Cuts Outlook Ahead of Restructuring

Dow Jones
·
Jul 29

Boston Scientific Trims Annual Profit Forecast on Softer Watchman Device Demand

Reuters
·
Jul 29

Ceribell Names Thomas West, Sharon O’Keefe to Board of Directors

Reuters
·
Jul 29

Stock Track | Boston Scientific Soars 6.32% in Pre-Market on Q2 Earnings Beat

Stock Track
·
Jul 29

Boston Scientific Q2 Adjusted Earnings, Revenue Rise; Lowers 2026 Guidance

MT Newswires Live
·
Jul 29

Boston Scientific Q2 Results Beat Estimates on Cardiovascular Strength

Reuters
·
Jul 29

GUIDANCE: (BSX) Boston Scientific Expects 2026 Adjusted EPS Range $3.28 to $3.32, vs. FactSet Est of $3.36

MT Newswires Live
·
Jul 29

Boston Scientific Q2 Adj. EPS $0.86 Beats $0.83 Estimate, Sales $5.442B Beat $5.361B Estimate

Benzinga Earnings
·
Jul 29